Subtotal: $110.00
Intrinsicly evisculate emerging cutting edge scenarios redefine future-proof e-markets demand line
A novel, centrally acting analgesic with dual mechanism of action
• Acts as agonist at mu-opioid receptor
• Causes noradrenaline reuptake inhibition
INDICATIONS:
• Cancer pain
• Traumatic pain
• Arthritic pain
• Post-operative pain
• Neuropathic pain
• Fibromyalgia
• Chronic back pain
Gravianz Pharma © 2025. All Rights Reserved.
Designed and Maintained by iShape Solution
